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Abstract
The zebrafish has become a powerful tool for analysis of vertebrate hematopoiesis. Zebrafish, unlike mam-
mals, have a robust primitive myeloid pathway that generates both granulocytes and macrophages. It is
not clear how this unique primitive myeloid pathway relates to mammalian definitive hematopoiesis. In
this study, we show that the two myeloid subsets can be distinguished using RNA in situ hybridization.
Using a morpholino-antisense gene knockdown approach, we have characterized the hematopoietic de-
fects resulting from knockdown of the myeloid transcription factor gene pu.1 and the unique zebrafish gene
c=ebp1. Severe reduction of pu.1 resulted in complete loss of primitive macrophage development, with
effects on granulocyte development only with maximal knockdown. Reduction of c=ebp1 did not ablate
initial macrophage or granulocyte development, but resulted in loss of expression of the secondary granule
gene lys C. These data reveal strong functional conservation of pu.1 between zebrafish primitive myelo-
poiesis and mammalian definitive myelopoiesis. Further, these results are consistent with a conserved role
between c=ebp1 and mammalian C=EBPE, whose ortholog in zebrafish has not been identified. These studies
validate the examination of zebrafish primitive myeloid development as a model for human myelopoiesis,
and form a framework for identification and analysis of myeloid mutants.
Introduction
In mammals, myelopoiesis occurs duringdefinitive hematopoiesis, through progres-
sive commitment and differentiation steps from
pluripotent hematopoietic stem cells to common
myeloid progenitors that ultimately generate
terminally differentiated erythroid, granulocyte,
and macrophage=monocyte lineages. The genes
that direct this process, including scl, spi-1=pu.1
(hereafter called pu.1), c=ebps, and gata1, have
been shown to play important roles not only
in normal hematopoiesis but also in leukemo-
genesis.1–5
Zebrafish have become a powerful vertebrate
model for analyses of hematopoiesis. Due to
the easy visibility of erythroid cells, over 26 he-
matopoietic mutants with abnormalities in ery-
throid populations have been identified.6 The
cloning of the genes mutated in these defects
has identified both known and novel genes
required for stem cell development, and de-
velopment and=or maintenance of the erythroid
lineage.7,8 In contrast to the early hematopoietic
screens that successfully identified alterations
in erythropoiesis, mutagenesis screens to ana-
lyze myeloid deficiencies are in the early stages.
The ability to design directed screens for mye-
loid defects requires a better understanding of
normal myelopoiesis in the zebrafish.
Zebrafish develop bothmacrophages and gra-
nulocytes during primitive hematopoiesis,9–11
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whilemammals generate largely erythroid cells,
with a small number of primitive macrophages
and no granulocytes, during primitive hema-
topoiesis.9–12 Due to the ease of examining early
events in the zebrafish, primitive myelopoiesis
is being used in most screens to assess myelo-
poiesis, although the parallels that can be drawn
between primitive myelopoiesis in zebrafish
and definitive myelopoiesis in mammals are not
known.
In the zebrafish, early markers of hemato-
poiesis are first evident by the 1–3 somite stage
or 11 hourspostfertilization (hpf ) in two regions,
the anterior lateral mesoderm (ALM) region
near the head and the posterior lateral meso-
derm (PLM), which later forms the intermedi-
ate cell mass (ICM).13 Erythroid development
takes place in the PLM=ICM, while macro-
phages develop from the ALM10 and granulo-
cytes may develop from the ALM and PLM.9,11
Transcription factors essential for myeloid
development in mammals include PU.1 and a
number of C=EBP family members. PU.1 is an
Ets-family transcription factor known to be
essential for macrophage and B lymphoid de-
velopment and some aspects of granulocyte
differentiation in mammals.14,15 The C=EBP
family of transcription factors includes several
members involved in hematopoietic develop-
ment. Orthologs of C=ebpa and C=ebpb have
been identified in the zebrafish.16 Interestingly,
an ortholog for C=ebpe, required for terminal
maturation of granulocytes and expression of
secondary granule proteins in mammals, has
not been identified in the zebrafish. However,
another C=ebp family member, C=ebp1, was
identified in zebrafish and is expressed specif-
ically in myeloid cells.17 The functional role of
C=ebp1 in myeloid development has not yet
been explored. Here we characterize the mye-
loid subsets present during primitive hema-
topoiesis and examine the functional roles of
Pu.1 and C=ebp1 through a morpholino (MO)–
based knockdown approach.
Results
Two myeloid subsets can be distinguished
in primitive zebrafish hematopoiesis
To characterize the myeloid cell populations
present in zebrafish embryos, whole-mount
embryos were examined by double RNA
in situ hybridizations using the myeloid-specific
markers l-plastin (lcp=l-pl),10 myeloperoxidase
(mpo),9 lysozyme C (lys C),18 macrophage colony–
stimulating factor receptor (csf1r=c-fms),19,20 and
CCAAT=enhancer binding protein 1 (c=ebp1).17
Previous work correlated the appearance of
l-pl expression with regions in which macro-
phages were visualized in live embryos.10,20
Further, l-pl has been shown to be coexpressed
in at least a subset of cells expressing c=ebp117
and lys C,18 while the majority of mpo-expressing
cells were found to be distinct from l-pl.9
However, further studies to distinguish clearly
amongst these multiple subsets have not been
performed.
Beginning at approximately 22–24hpf, two
populations of cells could be distinguished by
staining with l-pl, c-fms, mpo, and lys C. One
population present in both the tail and yolk sac
stained with mpo and lys C (Fig. 1C) and did
not express l-pl (Fig. 1A, B) or c-fms (Fig. 1D, E).
The second population, also present in yolk sac
and tail, costained with both l-pl and c-fms (Fig.
1F), but did not stain with lys C or mpo (Fig. 1D,
E). We conclude that the cells costaining with
l-pl and c-fms are likely macrophages given that
c-fms is expressed specifically in macrophages
in mammals21 and characterization of macro-
phages in zebrafish has correlated themovement
of these macrophages on video microscopy with
the positions of l-pl (þ) cells by RNA in situ hy-
bridization.10
mpo expression has been demonstrated in
adult zebrafish granulocytes by in situ hybrid-
izations in kidney sections.9 Thus, the mpo (þ)=
lys C (þ) population likely marks granulocytes
in embryos. While mpo and lys C staining was
largely coincident, prior to circulation (between
21 somites and 24 hpf ) there was a population
of mpo-staining cells that did not express lys C.
Single mpo–expressing cells were in the ICM
only (Fig. 2A), while double-staining mpo (þ)=
lys C (þ) cells were only present over the yolk
sac (Fig. 2B). The population of mpo (þ)=lys C
() cells in the ICM did not costain with gata1
(Fig. 2C) and was therefore clearly distinct from
erythroid progenitors. In mammals, myeloper-
oxidase is a primary granule protein, while
lysozyme is found in both primary and sec-
ondary granules. We therefore postulate that
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the single mpo–staining population may repre-
sent an earlier step in granulocyte maturation
prior to lys C expression.
In a previous work we identified a C=ebp
family member expressed only in myeloid cells,
which we called c=ebp1.17 c=ebp1 does not have
an ortholog in mammals, but has an identi-
fied ortholog in at least one other fish species
(GenBank accession no. AB049814). We have
shown previously that a subset of cells ex-
pressing l-pl coexpress c=ebp1.17 To determine
whether the mpo=lys C doubly positive pop-
ulation expressed c=ebp1, two-color staining
in situ hybridizations were performed at 28 hpf
with c=ebp1 and lys C. Two-color staining de-
monstrated coexpression of c=ebp1 with a sub-
set of lys C–expressing cells in the tail (Fig. 2D)
and yolk sac (data not shown). Thus, expres-
sion of c=ebp1 occurs in a subset of the cells of
both the macrophage and granulocyte lineages.
Macrophage development and granulocyte
development are differentially affected
in pu.1 MO–injected embryos
To examine the requirement for Pu.1 in zebra-
fish primitive myeloid development, pu.1 was
targeted in zebrafish embryos using MOs rec-
ognizing the pu.1 translation initiation site ( pu.1
init) or the exon 5 splice donor site ( pu.1 ex 5),
which is the most proximal exon to the Ets
domain, required for Pu.1 function.
To examine the efficacy of the pu.1 ex 5 MO,
we analyzed splice products from pu.1 ex 5
FIG. 1. Double in situ hybridization with myeloid markers. (A–F) 28 hpf embryos, lateral views of the tail, with em-
bryos oriented with the head to the left. Double in situ hybridizations were performed with dual fluorescent markers, as
indicated. Photographs taken with each filter were overlaid using Adobe Photoshop and are shown in (A–F). In (A1)
and (A2), individual pictures of an in situ hybridized embryo show signal from lys C taken using the rhodamine filter
(A1) or signal from l-pl using the FITC filter (A2). There is no ‘‘bleed-through’’ of signal seen with each filter. (A) is the
merged photo using (A1) and (A2). (A), (B), (D), and (E) signals are completely nonoverlapping (white arrows and
arrowheads), while in (C) and (F), overlapping signals result in yellow color (white arrows).
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MO–injected embryos. RNA at 21 somites was
harvested from pu.1 ex 5 MO–injected and pu.1
ex 5–misinjected embryos. Polymerase chain
reaction (PCR) primers spanning the exon 5
splice donor site were used to amplify pu.1
splice products (Fig. 3A). Three products were
detected from RNA recovered from pu.1 ex 5
MO–injected samples, and sequencing revea-
led that each product was distinct from the
wild-type product amplified from pu.1 ex 5–
misinjected or uninjected embryos (Fig. 3A, B).
There were three splice variants utilizing dif-
ferent cryptic splice donors and either the exon
6 splice acceptor or a cryptic acceptor (Fig. 3B,
C). Each of the products resulted in a predicted
translationproduct lacking thehighly conserved
Ets–DNA binding domain (Fig. 3C). Thus, all
products would be expected to result in non-
functional, prematurely truncated proteins.
There was no wild-type product detected.
Injection of pu.1 init (data not shown) or pu.1
ex 5 (Fig. 4) resulted in complete loss of l-pl in
86% of embryos (n¼ 82) compared to animals
injected with a control, mismatch MO, in which
100% of embryos expressed l-pl ( p< 0.001) (Fig.
4A, B). There was also loss of myeloid c-fms
staining in 100% of injected embryos (n¼ 38)
(Fig. 4D) compared to controls, which all stained
over the yolk sac for c-fms (n¼ 30; p< 0.001)
(Fig. 4C). Expression of c-fms in previously
described nonhematopoietic pigment cells=
neural crest cells on the dorsum of the tail19
was unaffected (Fig. 4C, D; arrowheads). Con-
trol embryos injected with equal amounts of
the negative control MO, pu.1 ex 5 mis (Fig. 4A,
C), or pu.1 init mis (data not shown) did not
affect staining with l-pl or c-fms. The costaining
results combined with the pu.1 MO results
demonstrated that therewas loss ofmacrophage
development in the absence of Pu.1.
While injection of either init or ex 5 pu.1 MO
resulted in complete loss of l-pl and c-fms
staining, expression of mpo and lys C was un-
affected in pu.1 MO–injected embryos (Fig. 4E–
H) in three independent experiments. Only
when a combination of the two MOs was in-
jected at a maximal concentration of 0.375mM
pu.1 init and 0.025mM pu.1 ex 5, was there loss
or severe reduction of mpo expression in 92% of
embryos (n¼ 38) and loss or severe reduction
in lys C expression in 67% of embryos (n¼ 45).
Injection of higher doses of the combination
was toxic, resulting in morphologic abnormal-
ities and lethality (data not shown).
To determine whether the phenotypic chan-
ges seen with the MO injections were due to
FIG. 2. Double in situ hybridization with myeloid markers and erythroid marker. (A–D) Double in situ hybridizations
with fast red colorimetric reaction and BM-Purple (Roche) color reaction with probes as marked. Twenty-twohpf
embryos are shown in (A–C) in lateral views, and a 28 hpf embryo is shown in (D) in lateral view. (A) ICM of embryo
double stained with mpo (red) and lys C (purple). (B) Yolk sac of embryo shown in (A) shows lys C staining. mpo
staining is coincident with lys C, with no cells staining with red only. (C) Tail of embryo double stained with mpo (red)
and gata1 (purple). Cells staining only with mpo are shown by the black arrow. The mpo-staining cells are distinct from
the gata1 (þ) erythroid population. (D) Tail of embryo stained with c=ebp1 (red) and lys C (purple). Cells expressing
both c=ebp1 and lys C are marked with a white arrow, while cells expressing only lys C are marked with a black arrow.
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specific loss of Pu.1, rescue experiments with
pu.1 mRNA were performed. mRNA synthe-
sized in vitro from pu.1 cDNA will not be rec-
ognized by the ex 5 MO since the splice donor
site is absent in normally spliced mRNA. Injec-
tion of pu.1 ex 5 MO (0.1mM) with pu.1 mRNA
(50 pg) resulted in rescue of l-pl expression in
79% of embryos (n¼ 85) compared to l-pl ex-
pression observed in only 13% of embryos in-
jected with MO alone ( p< 0.001) (Fig. 5A, B).
c=ebp1 is required for lys C expression
To evaluate the function of the transcription
factor C=ebp1 in myeloid development, we
used two translation initiation site MOs desig-
nated c=ebp1.1 and c=ebp1.2. Injection of either
MO alone or the combination resulted in sig-
nificant reduction or absence of lys C expres-
sion by 24 hpf in 85% of embryos (n¼ 79)
compared to controls in which lys C expression
was positive in 100% of embryos (n¼ 32) (Fig.
6E, F). In contrast, l-pl expression and mpo ex-
pression were unaffected (Fig. 6A–D). Further,
expression of c=ebp1 itself was significantly re-
duced or absent in 60–80% of embryos in three
independent experiments (Fig. 6G, H), consis-
tent with a model in which C=ebp1 autoregu-
lates its own expression.
c=ebp1 mRNA (50pg) lacking the 50 untrans-
lated region recognized by both MOs was co-
injected with each MO to assess rescue. Rescue
was incomplete, with lys C expression in 68%
of embryos coinjected with MO and mRNA
(n¼ 25) compared to expression of lys C in 15%
of embryos injected with MO alone (n¼ 79)
( p< 0.001). Injection of higher concentrations
of mRNA resulted in gross morphologic abnor-
malities. It is likely that due to the highly con-
served bZIP domain of c=ebp1, which contains
FIG. 3. RT-PCR with mRNA from pu.1 MO–injected embryos demonstrates aberrant splice products. (A) 2% agarose
gel electrophoresis with water control (H2O), mRNA from uninjected embryos (uninj), pu.1 ex 5 mis embryos (mis), and
pu.1 ex 5 MO embryos (ex5 MO). Three aberrant splice products were amplified, designated 1, 2, and 3. PCR products
were subcloned and sequenced. All products were different than the product amplified from uninjected and mis
controls. (B) Schematic showing pu.1 exon 5 and exon 6. PCR primer locations are indicated by black arrow, and the
region targeted by the exon 5 MO is shown. The cryptic splice sites are drawn and labeled 1, 2, and 3 as labeled in the
agarose gel in (A). (C) A region of DNA at the 30 end of exon 5 and the 50 end of exon 6 of pu.1 is shown. The predicted
translations for the splice products 1–3 all result in truncated products, with complete loss of the Ets domain encoded
by exon 6 (shown with horizontal shading).
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the dimerization and DNA binding regions,
widespread ectopic expression of c=ebp1 may
activate many genes controlled by the other
C=ebp family members. In support of this
speculation, in previous work it was also not
possible to inject gata1 mRNA without encoun-
tering toxicity, also likely due to ectopic acti-
vation of many Gata-responsive genes.8
To confirm the results of the c=ebp1 MO
knockdown, a g-ray deletion mutant, c1054,
which has a deletion in the distal portion of
linkage group 24 (M.E. Halpern and A. Fritz,
FIG. 4. Injection of ex 5 pu.1 MO results in loss of l-pl and c-fms expression. All embryos are 28 hpf and are shown in
lateral view with head to the left. Embryo shown is representative of all embryos under specified condition. (A, C, E,
and G) pu.1 ex 5 mis MO–injected embryos (ctrl MO). (B, D, F, and H) pu.1 ex 5 MO–injected embryos ( pu.1 MO). In
situ hybridizations were performed with the following markers: (A, B) l-pl, (C, D) c-fms, (E, F) mpo, and (G, H) lys C. In
(C), black arrows indicate myeloid-specific c-fms cell staining, and in (C) and (D), black arrowheads show neural crest-
derived pigment cell c-fms staining.
FIG. 5. Rescue of l-pl expression by pu.1 mRNA. Lateral views at 24 hpf are shown, with heads to the left. Embryos
were injected with pu.1 ex 5 MO. Approximately 50 pg negative control mRNA was injected in (A) and 50 pg of pu.1
mRNA was coinjected in (B). Rescue of l-pl expression is shown.
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unpublisheddata),where c=ebp1waspreviously
mapped,17 was examined. We analyzed the
deleted region in this mutant by amplification
from c1054 genomic DNA with primers within
c=ebp1 andflankingmarkers. These data showed
that the deleted region occurred distal to 64.5 cM
and spanned at least 71–72.1 cM, including
deletion of c=ebp1 (Fig. 7A, B). While multiple
genes are likely included in the deleted region,
the loss of c=ebp1 provided an opportunity to
confirm the MO results in homozygous c1054
mutant embryos.
Themutant embryos displayed normal expre-
ssion of the macrophage marker c-fms (n¼ 11)
(Fig. 7C, D) and the granulocyte marker mpo
(n¼ 17) (Fig. 7E), but had little or no expression
of lys C (n¼ 23) (Fig. 7F), confirming the find-
ings in the c=ebp1 MO–injected embryos. Thus,
in the absence of C=ebp1 expression, embryos
displayed normal l-pl, c-fms, and mpo expres-
sion, allowing us to draw the conclusion that
macrophages and granulocytes were present,
but either did not express lys C or lacked the
granules containing lys C.
Discussion
The use of the zebrafish for dissection of de-
velopmental pathways has gained prominence
over the past decade. While many mutants af-
fecting erythroid development have been iso-
lated, few mutants with myeloid defects have
been identified.22 Identification of genes ex-
pressed in myeloid cells has now allowed
the development of myeloid-specific muta-
genesis screens, but a detailed understanding
of the normal myelopoietic pathway is still
lacking.
An issue of great importance to these analyses
is the comparison of primitive myeloid devel-
opment in the zebrafish to the myeloid pro-
cesses that occur in higher vertebrates. In
zebrafish, both granulocytes and macrophages
develop between 21 somites (19.5 hpf ) and
FIG. 6. Embryos injected with c=ebp1 MOs demonstrate absence of lys C and c=ebp1 expression. All embryos are shown
in lateral viewwith head to the left. (A, C, E, andG) c=ebp1 mis 1MO–injected embryos (Ctrl MO). (B, D, F, andH) c=ebp1
MO–injected embryos. In situ hybridizations were performedwith the followingmarkers: (A, B) l-pl, (C, D) mpo, (E, F) lys
C, and (G, H) c=ebp1. (G, I) Black arrows indicate expression of the indicated marker in the tail of control embryos (E, G)
with minimal staining in c=ebp1 MO–injected embryos (F, H). White arrowheads indicate staining in yolk sac.
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3 days postfertilization (dpf ), during the prim-
itive wave of hematopoiesis.9,11 The great ad-
vantage of zebrafish is the ability to analyze
these early developmental events. However, it
is unclear how primitive myeloid development
in the zebrafish compares to primitive macro-
phage and, more importantly, definitive mye-
loid development in higher vertebrates.
Our studies reveal that two distinct myeloid
cell types can be distinguished in primitive
myelopoiesis by whole-mount RNA in situ
hybridization. The mpo=lys C double-staining
population labels the neutrophil=heterophil
population. In mammals, lysozyme expression
has been documented in both granulocytes and
macrophages. However, an in vivo tagging
study, using a Lysozyme promoter to drive
green fluorescent protein (GFP) expression in
mice, demonstrated that GFP was most highly
expressed in granulocytes, with much lower
expression in myelocyte progenitors and
monocytic cells.23 Our findings are consistent
with that work, showing that lysozyme is most
highly expressed in granulocytes.
The l-pl (þ) population in zebrafish has been
previously identified as a macrophage popu-
lation based on correlation of video microscopy
findings and l-pl (þ) cells by RNA in situ hy-
bridization.10,20 In humans, L-PL is expressed
in granulocytes, monocytes=macrophages, lym-
phocytes, and natural killer cells, and is fre-
quently expressed in both hematopoietic and
nonhematopoietic malignant cells.24 In contrast,
C-FMS, encoding the macrophage colony–
stimulating factor receptor, is expressed spe-
cifically in macrophages.25 The coexpression of
c-fms and l-pl, combined with previous work
correlating live macrophage movements with
in situ findings,10,20 demonstrates that the
l-pl–expressing cells are likely the monocyte=
macrophage population.
We used two different MOs recognizing pu.1
to assess Pu.1 ablation in zebrafish. Either MO
singly resulted in complete loss of l-pl and c-fms
FIG. 7. Deletion mutant lacking c=ebp1 has loss of lys C. (A) 2% agarose gel with products amplified from genomic
DNA. c=ebp1 primers amplified a product from wild-type (WT) fish genomic DNA, but not from the c1054 deletion
mutant. c=ebpd primers amplified product from both WT and c1054 deletion mutant. (B) Linkage group 24 map
showing relative positions of c=ebp1 and c=ebpd. To the right of the map are shown (þ) signs for DNA present in the
c1054 mutant, including c=ebpd and z9325 (data not shown). The () signs indicate DNA that is absent in the deletion
mutant, z20051 (data not shown), and c=ebp1. (C) Wild-type sibling (WT sib) at 24 hpf shows expression of c-fms. (D)
c1054 deletion homozygote at 24 hpf is stunted in appearance, but shows normal staining with c-fms. (E, F) 48 hpf c1054
deletion homozygotes are shown at 24 hpf in lateral position. While they have deformities due to the deletion in linkage
group 24, staining with (E) mpo is easily visible (shown by arrows), while there was no staining with (F) lys C.
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expression, while mpo expression and lys C ex-
pression were maintained, consistent with a spe-
cific loss of the macrophage lineage. When both
MOswere injected together at the highest dosage
possible without nonspecific toxicity, a signifi-
cant loss of mpo and lys C expression could be
achieved. These data suggest that a differential
threshold level of Pu.1 is needed for macrophage
development and granulocyte development.
A number of studies in mammals have iden-
tified graded requirements of Pu.1 for devel-
opment of hematopoietic lineages. In vivo, two
independent Pu.1 null mouse models have
been characterized.26,27 In both, development
of monocyte=macrophages was deficient, while
effects on neutrophil development were more
varied. Additional work with both models
showed that granulocyte commitment and early
gene expression, including expression of Mpo,
occurred in the absence of Pu.1.28–30 However,
formation of terminally differentiated, functio-
nal neutrophils did not occur without Pu.1.
Studies in tissue culture have demonstrated
that higher levels of Pu.1 are required for mac-
rophage development than for granulocyte31 or
B-cell development.32 Our work demonstrates
a definite requirement for pu.1 in macrophage
development, consistent with both mouse mo-
dels and in vitro studies. Granulocytes were
able to develop in the zebrafish with very low
levels of Pu.1 in our studies.
Recent work using a single pu.1 initiation
MO in zebrafish embryos demonstrated loss of
both macrophage and granulocyte develop-
ment with a single initiation site MO.33 It is
possible that the differences between our find-
ings and those of Rhodes et al.33 may be due to
greater Pu.1 knockdown using their MO. In-
terestingly, the translation initiation pu.1 MO
used by Rhodes et al.33 does not target the first
initiation ATG as did our init MO, but rather
the fifth in-frame ATG. It is possible that tran-
slation occurs from some of these more down-
stream in-frame ATGs, which might have
resulted in continued protein expression with
our translation initiation site MO.
Our analysis of the function of C=ebp1
demonstrated a role either in expression of lys
C or in myeloid development downstream of
mpo, but upstream of lys C. c=ebp1 is a myeloid-
specific c=ebp without a mammalian ortholog.17
While orthologs for C=EBPA and C=EBPB have
been identified in the zebrafish, a zebrafish
ortholog for C=EBPE has not been identified in
library screens16 or analysis of the available ge-
netic databases (S.E. Lyons, unpublished results).
We have postulated that C=ebp1may perform
an analogous function with C=EBPe. In humans
and mice, C=EBPe is required for expression
of secondary granule genes, as shown both by
mouse gene ablation studies34–36 and by the nat-
urally occurring human disorder due to mu-
tations in C=EBPe, neutrophil-specific granule
deficiency.35,37,38Myeloperoxidase is an enzyme
of primary granules, while lysozyme is an en-
zyme found in both primary and secondary
granules.39,40Additional secondarygranulepro-
teins have not yet been identified in zebrafish.
Our finding of mpo expression preceding lys C
expression in cells in the ICM suggests that
these cells may be earlier myeloid progeni-
tors. The isolated loss of lys C expression after
C=ebp1 ablation is consistent with a role for
C=ebp1 in terminal myeloid differentiation. We
can hypothesize that C=ebp1 may regulate lys
C or may act upstream of secondary granule
formation in granulocytes. The assessment of
C=ebp1 function in zebrafish myeloid devel-
opment suggests that it may play a functionally
conserved role with mammalian C=EBPe.41
Our data show that primitive myeloid devel-
opment in zebrafish results in at least two my-
eloid lineages,distinguishablebymultiplemark-
ers in RNA in situ hybridization. Using pu.1
and c=ebp1 MOs,we have begun to construct the
developmental pathways of primitive myeloid
development in the zebrafish (Fig. 8). The func-
tion of Pu.1 appears to be highly conserved from
mammalian definitivemyelopoiesis to zebrafish
primitivemyelopoiesis. The functions ofC=ebp1
may be conserved with mammalian C=EBPe.
These studies demonstrate that zebrafish pri-
mitive myeloid development can be used as
a model system with direct relevance to human
myeloid lineage development. They also reveal
the complexity of the myeloid pathway, and the
need to tailor mutagenesis screens to identify
myeloid mutants. The choice of the myeloid-
specific marker used in a mutagenesis screen
will determine the genes and specific pathways
that will be identified. Identification and char-
acterization of mutants with defects in myeloid
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marker expression has the potential to iden-
tify genes encoding direct upstream regulators
of myeloid proteins and effectors of lineage-
determination decisions. Future studies of
zebrafish embryonic myelopoiesis will greatly
enhance our understanding of the myeloid de-
velopmental pathway in vertebrates.
Materials and Methods
Zebrafish maintenance and breeding
Zebrafish were raised and maintained as de-
scribed previously,42 with EK strain wild-type
fish used for all studies. Embryos older than
24 hpf were treated with 0.003% 1-phenyl-2-
thiourea (Sigma, St. Louis, MO) to inhibit pig-
ment formation.
Whole-mount RNA in situ hybridization
Embryos were collected and whole-mount in
situ hybridization was performed as previously
described17 with minor modifications. Embryos
older than 24 hpf were treated with proteinase
K treatment at 10mg=mL for 5min, embryos at
2 dpf with 20 mg=mL for 20min, and embryos
at 3–4 dpf with 100mg=mL for 20min. Hybridi-
zation with probes and the subsequent washes
were all performed at 608C.
Antisense RNAs for in situ hybridization were
prepared as previously reported for lys C,18
mpo,9 l-pl,10 c-fms,19 gata1,13 and c=ebp1.17 Probes
were synthesized with digoxigenin (DIG)–
labeled uridine triphosphates (UTPs) according
to the manufacturer’s instructions (Roche, Basel,
Switzerland) or with fluorescein (FLUOR)–
labeled UTPs in the case of double staining.
For two-color staining, in situ hybridization
was performed as previously described.17 For
fluorescence two-color staining, embryos were
hybridized with both DIG-labeled and FLUOR-
labeled probes followed by posthybridization
incubation with anti-DIG-alkaline phosphatase
and anti-FLUOR horseradish peroxidase (HRP)
antibodies.43,44 Color=fluorescent staining was
performedwith Fast Red (Roche), which formed
a color precipitate that is also visible under
fluorescence using a rhodamine filter. The HRP-
conjugated antibody results in fluorescence
detectable with a fluorescein isothiocyanate
(FITC) filter using the tyramide signal amplifi-
cation (TSA)–biotin system (Perkin-Elmer,
Waltham, MA). Embryos were visualized on
a Leica MZFLIII dissecting microscope and
photographed with a Coolsnap digital camera.
MO microinjection
Embryos used for microinjection were ob-
tained from breeding wild-type EK strain zeb-
rafish. The following MOs were created by
GENE TOOLS, LLC (Philomath, OR; www
.Gene-Tools.com). Lower-case letters designate
mismatches, and underscore marks initiation
ATG.
pu.1 init (initiation site MO): 50-CCTCCATTCTGTAC
GGATGCAGCAT-30
pu.1 init mis (initiation site mismatch): 50-CgTCgATTC
TcTACGGATGgAGgAT-30
pu.1 ex 5 (exon 5 splice MO): 50-GGTCTTTCTCCTTAC
CATGCTCTCC-30
pu.1 ex 5 mis (exon 5 mismatch MO): 50-GGTgTTTgTC
CTTAgCATcCTgTCC-30
c=ebp1 1 (initiation MO 1): 50-CACCGACATGGCTGT
GTGTGGAGCT-30
c=ebp1 2 (initiation MO 2): 50-TGCTGAACTCTACTCG
ATCTCGTCC-30
c=ebp1 mis 1 (init 1 mismatch): 50-CAgCGAgATGggTG
TGTGTcGAcCT-30
c=ebp1 mis 2 (init 2 mismatch): 50-TcCTcAACTCTAgTC
GATCTgGTgC-30
MOs were injected in volumes of approxi-
mately 2 nL at concentrations ranging from
0.05 to 1.0mM (total quantities injected were
FIG. 8. Schematic of primitive myelopoiesis in zebrafish.
A proposed developmental pathway for myelopoiesis in
zebrafish embryos is shown with the transcription factors
Pu.1 and C=ebp1 placed in the pathway. Higher levels of
Pu.1 are needed for macrophage development, while low
levels are sufficient for granulocyte development, similar
to the gradient required in mammalian hematopoiesis.
C=ebp1 is shownupstreamof secondary granule formation
or regulating lys C expression in granulocyte development.
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approximately 1–20 ng). For each MO or MO
mix, injection concentrations were titrated to
determine the maximal injectable dose with mi-
nimal nonspecific morphologic abnormalities.
MO concentrations injected were as follows:
pu.1 init, 0.75mM; pu.1 ex 5, 0.1mM; pu.1
init=ex 5, 0.375mM=0.025mM; c=ebp1 init 1=2,
0.25mM each. The same concentrations of mis-
match were used for each corresponding MO.
Microinjections were performed according to
published protocols42 using a pneumatic pico-
pump (World Precision Instruments, Sarasota,
FL). All results were obtained in at least three
independent experiments with at least 20 em-
bryos=MO condition.
Analysis of mRNA splice products
After injection of embryos with pu.1 ex 5 or
ex 5 mis MOs, embryos were collected into
Trizol (Invitrogen, Carlsbad, CA) at the 21 so-
mite stage. RNA was isolated according to
manufacturer’s instructions. mRNA was used
for a reverse transcriptase reaction using ran-
dom oligonucleotides as primers followed by
PCR using the following primers targeting the
pu.1 cDNA between exon 5 and exon 6:
pu.1 exon 5 forward: 50-GACATCGGTGTGTTACCCT
C-30
pu.1 exon 6 reverse: 50-AGCAGGAACTGATACAAGC
G-30.
For analysis of the deleted region of the c1054
g-ray mutant, genomic DNA from a wild-type
control and c1054 were amplified with z-
marker primers and primers for c=ebp1 and
c=ebpd described previously.16,17
mRNA rescue
pu.1 and c=ebp1 cDNAs were amplified and
subcloned into pCS2þ45 digested with BamHI
and EcoRI. For c=ebp1, the forward primer be-
gins amplification at the ATG, removing the 50
untranslated sequence recognized by the c=ebp
MOs. The forward primers have a BamHI site










Capped mRNA was synthesized using an
mMessage RNA synthesis kit (Ambion, Foster
City, CA) as previously described.46
Embryos were injected at the one-cell stage
with appropriateMOs and 50–100 pg of mRNA.
Rescue was evaluated by in situ hybridization
for rescue of hematopoietic marker expression.
Embryos injected with 50–100 pg GFP mRNA
were used as negative control embryos.
Acknowledgments
We greatly appreciate the gift of deletion
mutant c1054 genomic DNA and embryos from
Andreas Fritz and Marnie Halpern. We thank
Dr. Doug Engel for critical reading of the
manuscript.
References
1. Begley CG, Aplan PD, Davey MP, Nakahara K,
Tchorz K, Kurtzberg J, et al. Chromosomal transloca-
tion in a human leukemic stem-cell line disrupts the
T-cell antigen receptor delta-chain diversity region and
results in a previously unreported fusion transcript.
Proc Natl Acad Sci USA 1989;86:2031–2035.
2. Mueller BU, Pabst T, Osato M, Asou N, Johansen LM,
Minden MD, et al. Heterozygous PU.1 mutations are
associated with acute myeloid leukemia. Blood 2002;
100:998–1007.
3. Pabst T, Mueller BU, Zhang P, Radomska HS, Nar-
ravula S, Schnittger S, et al. Dominant-negative muta-
tions of CEBPA, encoding CCAAT=enhancer binding
protein-alpha (C=EBPalpha), in acute myeloid leuke-
mia. Nat Genet 2001;27:263–270.
4. Shimizu R, Kuroha T, Ohneda O, Pan X, Ohneda K,
Takahashi S, et al. Leukemogenesis caused by inca-
pacitated GATA-1 function. Mol Cell Biol 2004;24:
10814–10825.
5. Crispino JD. GATA1 in normal and malignant hema-
topoiesis. Semin Cell Dev Biol 2005;16:137–147.
6. Shafizadeh E, Paw BH. Zebrafish as a model of human
hematologic disorders. Curr Opin Hematol 2004;11:
255–261.
7. Brownlie A, Zon L. The zebrafish as a model system
for the study of hematopoiesis. Zebrafish mutants
point the way to novel genes involved in the genera-
tion of vertebrate blood cells. Bioscience 1999;49:382–
392.
8. Lyons SE, Lawson ND, Lei L, Bennett PE, Weinstein
BM, Liu PP. A nonsense mutation in zebrafish gata1
causes the bloodless phenotype in vlad tepes. Proc
Natl Acad Sci USA 2002;99:5454–5459.
PU.1 AND C/EBP1 IN PRIMITIVE MYELOPOIESIS 197
9. Bennett CM, Kanki JP, Rhodes J, Liu TX, Paw BH,
Kieran MW, et al. Myelopoiesis in the zebrafish, Danio
rerio. Blood 2001;98:643–651.
10. Herbomel P, Thisse B, Thisse C. Ontogeny and beha-
viour of early macrophages in the zebrafish embryo.
Development 1999;126:3735–3745.
11. Lieschke GJ, Oates AC, Crowhurst MO, Ward AC,
Layton JE. Morphologic and functional characteriza-
tion of granulocytes and macrophages in embryonic
and adult zebrafish. Blood 2001;98:3087–3096.
12. Bahary N, Zon LI. Use of the zebrafish (Danio rerio)
to define hematopoiesis. Stem Cells 1998;16:89–98.
13. Detrich HW, 3rd, Kieran MW, Chan FY, Barone LM,
Yee K, Rundstadler JA, et al. Intraembryonic hema-
topoietic cell migration during vertebrate develop-
ment. Proc Natl Acad Sci USA 1995;92:10713–10717.
14. Fisher RC, Scott EW. Role of PU.1 in hematopoiesis.
Stem Cells 1998;16:25–37.
15. Simon MC. PU.1 and hematopoiesis: lessons learned
from gene targeting experiments. Semin Immunol
1998;10:111–118.
16. Lyons SE, Shue BC, Lei L, Oates AC, Zon LI, Liu PP.
Molecular cloning, genetic mapping, and expression
analysis of four zebrafish c=ebp genes. Gene 2001;281:
43–51.
17. Lyons SE, Shue BC, Oates AC, Zon LI, Liu PP. A
novel myeloid-restricted zebrafish CCAAT=enhancer-
binding protein with a potent transcriptional activa-
tion domain. Blood 2001;97:2611–2617.
18. Liu F, Wen Z. Cloning and expression pattern of the
lysozyme C gene in zebrafish. Mech Dev 2002;113:
69–72.
19. Parichy D, Ransom D, Paw B, Zon L, Johnson S. An
orthologue of the kit-related gene fms is required for
development of neural crest-derived xanthophores and
a subpopulation of adult melanocytes in the zebra-
fish, Danio rerio. Development 2000;127:3031–3044.
20. Herbomel P, Thisse B, Thisse C. Zebrafish early mac-
rophages colonize cephalic mesenchyme and devel-
oping brain, retina, and epidermis through a M-CSF
receptor-dependent invasive process. Dev Biol 2001;
238:274–288.
21. Tagoh H, Himes R, Clarke D, Leenen PJ, Riggs AD,
Hume D, et al. Transcription factor complex formation
and chromatin fine structure alterations at the murine
c-fms (CSF-1 receptor) locus during maturation of my-
eloid precursor cells. Genes Dev 2002;16:1721–1737.
22. Hogan BM, Layton JE, Pyati UJ, Nutt SL, Hayman JW,
Varma S, et al. Specification of the primitive myeloid
precursor pool requires signaling through Alk8 in
zebrafish. Curr Biol 2006;16:506–511.
23. Faust N, Varas F, Kelly LM, Heck S, Graf T. Insertion
of enhanced green fluorescent protein into the lyso-
zyme gene creates mice with green fluorescent gran-
ulocytes and macrophages. Blood 2000;96:719–726.
24. Lin CS, Park T, Chen ZP, Leavitt J. Human plastin
genes. Comparative gene structure, chromosome lo-
cation, and differential expression in normal and neo-
plastic cells. J Biol Chem 1993;268:2781–2792.
25. Woolford J, Rothwell V, Rohrschneider L. Character-
ization of the human c-fms gene product and its ex-
pression in cells of the monocyte-macrophage lineage.
Mol Cell Biol 1985;5:3458–3466.
26. Scott EW, Simon MC, Anastasi J, Singh H. Require-
ment of transcription factor PU.1 in the development
of multiple hematopoietic lineages. Science 1994;265:
1573–1577.
27. McKercher SR, Torbett BE, Anderson KL, Henkel
GW, Vestal DJ, Baribault H, et al. Targeted disruption
of the PU.1 gene results in multiple hematopoietic
abnormalities. EMBO J 1996;15:5647–5658.
28. Anderson KL, Smith KA, Conners K, McKercher SR,
Maki RA, Torbett BE. Myeloid development is selec-
tively disrupted in PU.1 null mice. Blood 1998;91:
3702–3710.
29. Anderson KL, Smith KA, Pio F, Torbett BE, Maki RA.
Neutrophils deficient in PU.1 do not terminally dif-
ferentiate or become functionally competent. Blood
1998;92:1576–1585.
30. Olson MC, Scott EW, Hack AA, Su GH, Tenen DG,
Singh H, et al. PU.1 is not essential for early myeloid
gene expression but is required for terminal myeloid
differentiation. Immunity 1995;3:703–714.
31. Dahl R, Walsh JC, Lancki D, Laslo P, Iyer SR, Singh H,
et al. Regulation of macrophage and neutrophil cell
fates by the PU.1:C=EBPalpha ratio and granulocyte
colony-stimulating factor. Nat Immunol 2003;4:1029–
1036.
32. DeKoter RP, Singh H. Regulation of B lymphocyte
and macrophage development by graded expression
of PU.1. Science 2000;288:1439–1441.
33. Rhodes J, Hagen A, Hsu K, Deng M, Liu TX, Look AT,
et al. Interplay of pu.1 and gata1 determines myelo-
erythroid progenitor cell fate in zebrafish. Dev Cell
2005;8:97–108.
34. Gombart AF, Kwok SH, Anderson KL, Yamaguchi Y,
Torbett BE, Koeffler HP. Regulation of neutrophil and
eosinophil secondary granule gene expression by
transcription factors C=EBP epsilon and PU.1. Blood
2003;101:3265–3273.
35. Gombart AF, Koeffler HP. Neutrophil specific granule
deficiency and mutations in the gene encoding tran-
scription factor C=EBP(epsilon). Curr Opin Hematol
2002;9:36–42.
36. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla
LH, Liu PP, Eckhaus M, et al. Impaired granulopoiesis,
myelodysplasia, and early lethality in CCAAT=
enhancer binding protein epsilon-deficient mice. Proc
Natl Acad Sci USA 1997;94:13187–13192.
37. Lekstrom-Himes JA, Dorman SE, Kopar P, Holland
SM, Gallin JI. Neutrophil-specific granule deficiency
results from a novel mutation with loss of function of
the transcription factor CCAAT=enhancer binding
protein epsilon. J Exp Med 1999;189:1847–1852.
38. Gombart AF, Shiohara M, Kwok SH, Agematsu K,
Komiyama A, Koeffler HP. Neutrophil-specific gran-
ule deficiency: homozygous recessive inheritance of a
frameshift mutation in the gene encoding transcription
198 SU ET AL.
factor CCAAT=enhancer binding protein-epsilon.
Blood 2001;97:2561–2567.
39. Cramer EM, Breton-Gorius J. Ultrastructural localiza-
tion of lysozyme in human neutrophils by immuno-
gold. J Leukoc Biol 1987;41:242–247.
40. Shaft D, Shtalrid M, Berebi A, Catovsky D, Resnitzky
P. Ultrastructural characteristics and lysozyme content
in hypergranular and variant type of acute promye-
locytic leukaemia. Br J Haematol 1998;103:729–739.
41. Lekstrom-Himes JA. The role of C=EBP(epsilon) in the
terminal stages of granulocyte differentiation. Stem
Cells 2001;19:125–133.
42. Westerfield M. The Zebrafish Book: A Guide for the Labo-
ratory Use of Zebrafish (Danio rerio), 3rd ed. University
of Oregon Press, Eugene, Oregon, 1995.
43. Raymond PA, Barthel LK. A moving wave patterns
the cone photoreceptor mosaic array in the zebrafish
retina. Int J Dev Biol 2004;48:935–945.
44. Barthel LK, Raymond PA. In situ hybridization stud-
ies of retinal neurons. In: K. Palczewsk (ed). Methods in
Enzymology-Vertebrate Phototransduction and the Visual
Cycle. Academic Press, Orlando, FL, 2000, pp. 579–
590.
45. Turner DL, Weintraub H. Expression of achaete-scute
homolog 3 in Xenopus embryos converts ectodermal
cells to a neural fate. Genes Dev 1994;8:1434–1447.
46. Juarez MA, Su F, Chun S, Kiel MJ, Lyons SE. Dis-
tinct roles for SCL in erythroid specification and
maturation in zebrafish. J Biol Chem 2005;280:41636–
41644.
Address reprint requests to:
Susan E. Lyons, M.D., Ph.D.
2215 Fuller Road
Room B740
Ann Arbor, MI 48105
E-mail: suslyons@umich.edu
PU.1 AND C/EBP1 IN PRIMITIVE MYELOPOIESIS 199

This article has been cited by:
1. C. Liongue, C. J. Hall, B. A. O'Connell, P. Crosier, A. C. Ward. 2009. Zebrafish granulocyte colony-stimulating factor receptor
signaling promotes myelopoiesis and myeloid cell migration. Blood 113:11, 2535-2546. [CrossRef]
2. Kevin B. Walters, M. Ernest Dodd, Jonathan R. Mathias, Andrea J. Gallagher, David A. Bennin, Jennifer Rhodes, John P.
Kanki, A. Thomas Look, Yevgenya Grinblat, Anna Huttenlocher. 2009. Muscle degeneration and leukocyte infiltration caused
by mutation of zebrafish fad24. Developmental Dynamics 238:1, 86-99. [CrossRef]
3. 2007. Recent Papers on Zebrafish and Other Aquarium Fish ModelsRecent Papers on Zebrafish and Other Aquarium Fish Models.
Zebrafish 4:4, 297-308. [Citation] [PDF] [PDF Plus]
